Neurology & Cognitive Research
Advancing Alzheimer’s Clinical Research
Alzheimer’s disease affects millions of individuals and families worldwide, creating an urgent need for innovative therapies and early intervention strategies. CenExel partners with sponsors to support cutting-edge Alzheimer’s clinical trials focused on memory loss, cognitive decline, and neurodegenerative conditions across diverse patient populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Leading Alzheimer’s Clinical Research
CenExel provides specialized expertise in Alzheimer’s and neurodegenerative clinical trials, combining scientific leadership with experienced operational teams. Our sites support early-phase through late-stage studies focused on cognitive disorders, dementia care, biomarker analysis, and patient-centered research solutions.
Conditions Covered
Alzheimer’s & Cognitive Conditions We Research
Our Alzheimer’s research sites support a broad range of neurodegenerative and cognitive disorders across adult and aging populations.
- Alzheimer’s Disease
- Mild Cognitive Impairment (MCI)
- Dementia
- Early-Onset Alzheimer’s
- Memory Loss Disorders
- Parkinson’s Disease Dementia
- Vascular Dementia
- Lewy Body Dementia
Our Approach
Why Sponsors Choose CenExel for Alzheimer’s Research
Our Alzheimer’s research network combines neurology expertise, advanced diagnostics, and patient-focused recruitment strategies to support successful clinical outcomes.
01
Specialized Neurology Teams
Experienced investigators and coordinators focused on cognitive and neurodegenerative disorders.
02
Biomarker & Imaging Support
Support for MRI, PET imaging, and biomarker-driven Alzheimer’s studies.
03
Diverse Patient Recruitment
Access to broad and aging patient populations across multiple U.S. locations.
04
Efficient Enrollment Performance
Optimized recruitment and retention strategies for Alzheimer’s clinical trials.
Phase Coverage
Supported Alzheimer’s Trial Phases
CenExel supports early and late-stage Alzheimer’s clinical trials — from first-in-human studies through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced neurology research teams support biomarker validation, cognitive testing, imaging studies, and long-term Alzheimer’s disease management trials.
Alzheimer’s Task Force
CenExel supports Alzheimer’s and cognitive disorder studies with experienced neurology investigators, specialized memory assessment teams, and access to diverse patient populations across multiple research sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
